Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 13
2004 6
2005 9
2006 7
2007 6
2008 10
2009 21
2010 22
2011 31
2012 37
2013 38
2014 34
2015 43
2016 42
2017 47
2018 37
2019 38
2020 86
2021 117
2022 137
2023 147
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

849 results

Results by year

Filters applied: . Clear all
Page 1
The people behind the papers.
Agarwal M, Sharma A, Kumar P, Kumar A, Mathew S. Agarwal M, et al. Among authors: kumar p. Development. 2020 Apr 6;147(7):dev190025. doi: 10.1242/dev.190025. Development. 2020. PMID: 32253256
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
Kumar SK, Jacobus SJ, Cohen AD, Weiss M, Callander N, Singh AK, Parker TL, Menter A, Yang X, Parsons B, Kumar P, Kapoor P, Rosenberg A, Zonder JA, Faber E Jr, Lonial S, Anderson KC, Richardson PG, Orlowski RZ, Wagner LI, Rajkumar SV. Kumar SK, et al. Among authors: kumar p. Lancet Oncol. 2020 Oct;21(10):1317-1330. doi: 10.1016/S1470-2045(20)30452-6. Epub 2020 Aug 28. Lancet Oncol. 2020. PMID: 32866432 Free PMC article. Clinical Trial.
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
Meyerhardt JA, Shi Q, Fuchs CS, Meyer J, Niedzwiecki D, Zemla T, Kumthekar P, Guthrie KA, Couture F, Kuebler P, Bendell JC, Kumar P, Lewis D, Tan B, Bertagnolli M, Grothey A, Hochster HS, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF. Meyerhardt JA, et al. Among authors: kumar p. JAMA. 2021 Apr 6;325(13):1277-1286. doi: 10.1001/jama.2021.2454. JAMA. 2021. PMID: 33821899 Free PMC article. Clinical Trial.
Nanopaper Biosensors at Point of Care.
Kumar P, Sarkar N, Singh A, Kaushik M. Kumar P, et al. Bioconjug Chem. 2022 Jun 15;33(6):1114-1130. doi: 10.1021/acs.bioconjchem.2c00213. Epub 2022 Jun 5. Bioconjug Chem. 2022. PMID: 35658426 Review.
Defining the Middle Corona.
West MJ, Seaton DB, Wexler DB, Raymond JC, Del Zanna G, Rivera YJ, Kobelski AR, Chen B, DeForest C, Golub L, Caspi A, Gilly CR, Kooi JE, Meyer KA, Alterman BL, Alzate N, Andretta V, Auchère F, Banerjee D, Berghmans D, Chamberlin P, Chitta LP, Downs C, Giordano S, Harra L, Higginson A, Howard RA, Kumar P, Mason E, Mason JP, Morton RJ, Nykyri K, Patel R, Rachmeler L, Reardon KP, Reeves KK, Savage S, Thompson BJ, Van Kooten SJ, Viall NM, Vourlidas A, Zhukov AN. West MJ, et al. Among authors: kumar p. Sol Phys. 2023;298(6):78. doi: 10.1007/s11207-023-02170-1. Epub 2023 Jun 14. Sol Phys. 2023. PMID: 37325237 Free PMC article. Review.
Authors' reply to Reed.
Warraich HJ, Kumar P, Wadhera RK. Warraich HJ, et al. Among authors: kumar p. BMJ. 2022 Jul 26;378:o1871. doi: 10.1136/bmj.o1871. BMJ. 2022. PMID: 35882399 No abstract available.
849 results